Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (BEIGF) Assets Average (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Assets Average for 10 consecutive years, with $7.9 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 34.63% to $7.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 billion through Dec 2025, up 34.63% year-over-year, with the annual reading at $7.1 billion for FY2025, 20.32% up from the prior year.
  • Assets Average for Q4 2025 was $7.9 billion at BeOne Medicines, up from $7.0 billion in the prior quarter.
  • The five-year high for Assets Average was $8.3 billion in Q1 2022, with the low at $5.4 billion in Q3 2021.
  • Average Assets Average over 5 years is $6.3 billion, with a median of $5.9 billion recorded in 2023.
  • The sharpest move saw Assets Average soared 101.11% in 2021, then plummeted 30.92% in 2023.
  • Over 5 years, Assets Average stood at $6.9 billion in 2021, then decreased by 11.68% to $6.1 billion in 2022, then dropped by 7.18% to $5.7 billion in 2023, then increased by 3.72% to $5.9 billion in 2024, then surged by 34.63% to $7.9 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $7.9 billion, $7.0 billion, and $6.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.